Document is current
Any future updates will be listed below
-
Authors
Masana, Lluís
Correig, Eudald
Ibarretxe, Daiana
Anoro, Eva
Arroyo, Juan Antonio
Jericó, Carlos
Guerrero, Carolina
Miret, Marcel·la
Näf, Silvia
Pardo, Anna
Perea, Verónica
Pérez-Bernalte, Rosa
Plana, Núria
Ramírez-Montesinos, Rafael
Royuela, Meritxell
Soler, Cristina
Urquizu-Padilla, Maria
Zamora, Alberto
Pedro-Botet, Juan
,
Rodríguez-Borjabad, Cèlia
Andreychuk, Natalia
Malo, Ana
Matas, Laia
del Señor Cortes-Fernandez, Maria
Mauri, Marta
Borrallo, Rosa M.
Pedragosa, Àngels
Gil-Lluís, Pilar
Lacal-Martínez, Ana
Barragan-Galló, Patricia
Vives-Masdeu, Glòria
Arto-Fernández, Carmen
Boutrouki, Omar El
Vázquez-Escobales, Andrea
Antón-Alonso, Maria Cristina
Rivero-Santana, Sergio
Gómez, Albert
García, Sara
Rial-Lorenzo, Núria
Ruiz-Ortega, Lourdes
Alonso-Gisbert, Oriol
Méndez-Martínez, Ana Inés
Iglesias-López, Hada
Climent, Elisenda
Güerri, Roberto
Soldado, Jade
Fanlo, Marta
Taboada, Alicia
Gutierrez, Liliana
-
Funding
Funding for this research was provided by:
Xarxa Unitats de Lipids i Arteriosclerosi de Catalunya (Stacov)
Institut de Investigació Sanitaria Pere Virgili
- License Information
-
More Information
Article History
Received: 8 December 2020
Accepted: 15 March 2021
First Online: 30 March 2021
Competing interests
: L. Masana: Has received personal fees for lectures and/or advisory work from Amgen, Sanofi, Mylan, Servier, MSD, Novartis, and Daiichi-Sankyo.N. Plana: Personal fees for lectures from Amgen, Mylan, and Sanofi. J. Pedro-Botet: Personal fees for lectures and/or advisory work from Amgen, Astra-Zeneca, Esteve, Ferrer, MSD, Mylan, Sanofi, Servier, and Rovi. C. Soler: Personal fees for lectures from Almirall, MSD, VISO farmacèutica, Mylan, and Esteve. M. Miret: Personal fees for lectures and/or advisory work from Sanofi, Novartis, Novonordisk, Astra-Zeneca, Esteve, Lilly, MSD, Ferrer, and Janssen, C. Jericó: Personal fees for lectures and/or advisory work from Sanofi, Amgen, MSD, Ferrer, Astra-Zeneca, Boehringer-Ingelheim, Lilly, Esteve, Novo-Nordisk, and Rovi. D. Ibarretxe: Personal fees for lectures from Sanofi, Rubió.E. Anoro, E. Correig, A. Pardo, C. Guerrero, S. Naf, JA. Arroyo, M. Urquizu-Padilla, V. Perea, R. Pérez-Berbalte, R. Ramirez-Montesinos, M. Royuela, and A. Zamora: Declare no conflicts of interest.
